Metformin Use May Improve Survival in Patients With CRC, Diabetes
Research indicates that metformin can confer improved survival for patients with colorectal cancer that also have diabetes.
Diagnosis & Disease Information
Metformin May Reduce Cancer Mortality Risk for Women
Older women with diabetes and cancer taking metformin saw an increase in survival.
Metformin linked to reduced head and neck cancer risk
Diabetes patients treated with the drug less likely to develop oropharyngeal and nasopharyngeal cancers.
Metformin may not increase survival of patients with pancreatic cancer
Therapy with metformin use did not improve survival of patients with pancreatic ductal adenocarcinoma (PDAC), according to recent study data.
Metformin use doesn’t reduce bladder cancer incidence
For patients with type 2 diabetes, metformin use is not associated with a significantly reduced risk of bladder cancer, according to a study.
Clinical trial data on metformin for cancer are showing conflicting results
The diabetes drug metformin is undergoing investigation as a potential treatment for different cancers in numerous clinical trials, but results vary.
More metformin may be needed for breast cancer patients with high glucose levels
Breast cancer cell growth, motility, and aggression is promoted by excess glucose, as experienced by patients with diabetes and metabolic syndrome, reports a new study.
- Loading...
Loading...
Loading... 
Loading...